Literature DB >> 10820009

Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase.

L B Pritzker1, S Joshi, G Harauz, M A Moscarello.   

Abstract

Deimination of myelin basic protein (MBP) has been implicated in the chemical pathogenesis of multiple sclerosis (MS). Degradation of bovine MBP by cathepsin D, a myelin-associated protease, was increased when 6 arginyl residues were deiminated and became very rapid when all 18 arginyl residues were deiminated. Since MBP contains a number of modifications, including methylation, phosphorylation, etc., we studied the effect of methylation, an irreversible modification, to determine how this modification affected deimination. Methylation of Arg 106 in bovine MBP (Arg 107 in human), a naturally occurring modification of MBP, has been shown to affect the deimination of arginyl residues in the present study. Since fractionation of MBP into unmethylated, monomethylated, and dimethylated species cannot be done readily on a preparative scale, mass spectrometry with the Q-TOF instrument resolved these species readily since each differed from the other by 14 atomic mass units (amu). Examination of five different hMBP samples, two from normal brain and three from MS brain, revealed that increased deimination of arginyl residues correlated with a decreased methylation of Arg 107 (human sequence). To study this process in vitro, bovine MBP (bMBP) was used. Component 1 (C-1) is the most cationic of the MBP "charge isomers" and the most unmodified, in which all arginyl residues are intact. It was deiminated to various extents with purified bovine brain peptidylarginine deiminase, generating a number of species containing 0-13.7 mol of citrulline/mol of bMBP. Mass spectrometry of each of these species permitted us to determine the influence of methylation of Arg 106 (bovine sequence) on deimination by this enzyme. We found that bMBP with unmethylated arginine was deiminated at a rate of 0.081 mol of citrulline/min, with monomethylarginine, 0.068 mol of citrulline/min, and with dimethylarginine, 0.036 mol of citrulline/min. We suggest that the methylated arginyl residue becomes sequestered in the hydrophobic beta-sheet structure and disrupts the three-dimensional structure of the protein so that other arginyl residues are less accessible to peptidylarginine deiminase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820009     DOI: 10.1021/bi9925571

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Interactions of the 18.5 kDa isoform of myelin basic protein with Ca2+-calmodulin: in vitro studies using gel shift assays.

Authors:  David S Libich; George Harauz
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  Myelin basic protein undergoes a broader range of modifications in mammals than in lower vertebrates.

Authors:  Chunchao Zhang; Angela K Walker; Robert Zand; Mario A Moscarello; Jerry Mingtao Yan; Philip C Andrews
Journal:  J Proteome Res       Date:  2012-09-21       Impact factor: 4.466

Review 3.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

4.  Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation.

Authors:  Zhicheng Jin; Zongming Fu; Jun Yang; Juan Troncosco; Allen D Everett; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-08-07       Impact factor: 3.984

Review 5.  New insights into the biology and pathobiology of beta2-glycoprotein I.

Authors:  Bill Giannakopoulos; Peyman Mirarabshahi; Steven A Krilis
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 6.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

7.  Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope.

Authors:  Abdiwahab A Musse; Joan M Boggs; George Harauz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-09       Impact factor: 11.205

Review 8.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

9.  Molecular dynamics exposes alpha-helices in myelin basic protein.

Authors:  Ian R Bates; George Harauz
Journal:  J Mol Model       Date:  2003-07-24       Impact factor: 1.810

10.  Interaction of the 18.5-kD isoform of myelin basic protein with Ca2+ -calmodulin: effects of deimination assessed by intrinsic Trp fluorescence spectroscopy, dynamic light scattering, and circular dichroism.

Authors:  David S Libich; Christopher M D Hill; Ian R Bates; F Ross Hallett; Souzan Armstrong; Aleksander Siemiarczuk; George Harauz
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.